NCT03934684 2025-08-06
Study to Evaluate Safety Tolerability & Efficacy of Kyprolis (Carfilzomib) in Relapsed or Refractory Multiple Myeloma
Amgen
Phase 4 Completed
Amgen
Montefiore Medical Center
Columbia University
Merck Sharp & Dohme LLC
University of Chicago